PRO 2000: Began Phase I trial to test safety and pharmacokinetics in a dose-escalation format

Procept Inc. (PRCT), Cambridge, Mass. Product: PRO 2000, which binds to the CD4 receptor on T cells Indication: HIV infection Status: Began Phase I trial to test safety and pharmacokinetics in a dose...